The prevalence of cryptococcal antigenemia among patients with HIV in the United States is approximately 2900 per 100,000 patients. The overall incidence is estimated to be 0.4 to 1.3 cases per 100,000 persons yearly in the United States.<unk>  has no age, gender, or racial predilections.
Cryptococcosis epidemiology and demographics
Histoplasmosis epidemiology and demographics
Toxoplasmosis epidemiology and demographics
Psittacosis epidemiology and demographics
Echinococcosis epidemiology and demographics
Blastomycosis epidemiology and demographics
Coccidioidomycosis epidemiology and demographics
Aspergillosis epidemiology and demographics